Medicamen Biotech Limited — Others, 31-12-2024: Trading Window

The Trading Window for Medicamen Biotech Limited will be closed for Directors and Designated Persons starting January 1, 2025, until 48 hours after the announcement of the interim financial results for the quarter ended December 31, 2024. This measure is a standard procedure aimed at preventing insider trading before the results are made public. Such closures can create a cautious sentiment among investors, potentially limiting trading activity but generally signify an upcoming financial update, which might offer clarity on the company’s performance and future direction.